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A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis
Ivan Columbus Morales MD1, Taha Ashraf MD1, Humberto Gonzalez MD2, Stuart Gordon MD2
1Department of Internal Medicine, Henry Ford Hospital, Detroit, MI
2Department of Gastroenterology, Henry Ford Hospital, Detroit, MI

Introduction

Pathology

Haemophagocytic lymphohistiocytosis (HLH) is a rare clinical
syndrome characterized by fever, hepatosplenomegaly, cytopenias,
presence of activated macrophages in hematopoietic organs and
progressive multiple-organ failure.1 The secondary form of HLH is
often triggered by infections, malignancies, and autoimmune diseases.2
Disseminated histoplasmosis (DH) has been described as a potential
trigger, most commonly in immunocompromised hosts. The
pathogenetic mechanisms behind HLH are not well understood but
involve cytotoxic lymphocyte dysfunction leading to an exaggerated
inflammatory response, which ultimately causes tissue damage and
progressive multiple organ failure.3 The liver, spleen, and lungs are the
most frequently affected organs, but HLH can potentially affect all
tissues in the human body. Patients with HLH are often severely ill
making the establishment of the diagnosis challenging.

Figure 1. Hematoxylin and Eosin stain. Liver biopsy showing non-caseating granulomas
and intracellular fungal organisms.

Case Presentation
A 42-year-old female presented to the emergency department with a 2week history of jaundice, intermittent right upper quadrant abdominal pain
and fevers. Her past medical history was significant for ankylosing
spondylitis for which she was on chronic immunosuppression with
prednisone, methotrexate and infliximab. On admission she had abnormal
liver biochemistries (AST 538 unit/L, ALT 132 unit/L, alkaline phosphatase
623 unit/L, total bilirubin 6.9 mg/dL, direct bilirubin 6.2 mg/dL, INR 2.1).
Other laboratory values included ferritin (20,308 ng/dL) and triglycerides
(1409 mg/dL) as well as low levels of fibrinogen (105 mg/dL). Blood
cultures, viral hepatitis panel, autoimmune panel, ceruloplasmin and
cytomegalovirus DNA were negative. A right upper quadrant
ultrasonography revealed cholelithiasis, gallbladder wall thickening and
splenomegaly. She was initially started on broad-spectrum antibiotics to
treat for suspected acute cholangitis. A subsequent MRCP showed no
evidence of intra- or extrahepatic biliary dilatation.
The patient clinically deteriorated with worsening mentation, persistent
fever, need of vasopressor support and mechanical ventilation. The hospital
course was further complicated by a tonic-clonic seizure and anuric acute
kidney failure requiring renal replacement therapy. Given the clinical
decline and uncertainty of the source of sepsis, antimicrobial coverage was
broadened to include amphotericin B and acyclovir; a liver biopsy was
performed revealing marked granulomatous inflammation with numerous
intracellular organisms that were morphologically compatible with
Histoplasma (Figure 1 & 2). Serum histosplasma antigen was also positive.
A bone marrow biopsy was obtained revealing hemophagocytic cells
(Figure 3).
Since the patient met diagnostic criteria for HLH, she was started on
dexamethasone and etoposide. The patient received a total of 14 days of
amphotericin B and then was transitioned to oral itraconazole. She steadily
recovered, resolving the renal failure, allowing for discharge home.

Figure 2. Grocott-Gomori Methenamine Silver stain. Intracellular budding yeast forms.

Discussion
• Histoplasmosis is the most common endemic mycosis in the
United States is usually transmitted after inhalation of the
organism, which is present in soils contaminated by bird or bat
droppings5.
• The disseminated form is more common in the
immunocompromised host and extreme of ages. Liver involvement
presents with abnormal liver biochemistries.
• Diagnostic tests include blood cultures, antigen detection,
polymerase chain reaction assays and direct microscopic
examination.
• DH is treated with amphotericin B for severe infections and
itraconazole for mild to moderate disease.
• HLH presents as a febrile illness with multiorgan involvement
including splenomegaly, cytopenias, coagulation abnormalities,
extreme
hyperferritinemia,
hypertriglyceridemia,
hemophagocytosis, and elevation of the soluble IL 2 receptor.
• Infection-related HLH cases should be treated aggressively with
standard HLH protocols that include dexamethasone, etoposide
and cyclosporine.

Conclusion

Figure 3. Hemophagocytosis in bone marrow aspirate smear. The photomicrograph depicts
a macrophage in the center of the smear ingesting nucleated red cell precursors.

• This case portraits the challenges of diagnosing DH given the diverse
clinical manifestations
• The presence of persistent fever and a cholestatic biochemical profile
should raise the index of suspicion in the right clinical setting.
• Awareness of HLH avoids missing a life-threatening condition, but
also prevents overdiagnosis that can lead to administration of
corticosteroids and cytotoxic agents in critically ill individuals.
• Early recognition is crucial for a reasonable attempt at curative
therapy, as treating the triggering event alone is usually not sufficient.
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